JAZZ News and Press, Jazz Pharmaceuticals plc From 02/16/21

Jazz Pharmaceuticals Completes Submission of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia PR Newswire DUBLIN , Feb. 16, 2021 /PRNewswire/ -- Jazz Pharmaceuti...

– Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year – – Total Epidiolex ® net product sales of $144.1 million for the fourth quarter and $510.5 million for the full year – –...

The CBD market has recently seen a multibillion-dollar deal and Hempfusion going public. Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join the show to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity i...

In the past few months, some big deals have taken place in the cannabis industry. In December 2020, there was news of a near-$4 billion merger including Canadian pot giants Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) , which will create the largest cannabis company in th...

Cannabis stocks are again higher this morning as the Reddit/WSB traders turn their focus to the sector. Marijuana names were already having a party since the beginning of February, given Jazz Pharmaceuticals' (JAZZ) $7.2B deal for medical cannabinoid firm GW Pharma (GWPH) and Tilray's (TLRY) ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Something is bumbling Another glitzy IPO will begin trading today as a strong streak continues for stocks and the public markets. Bumble, the hot app which...

Avadel's flagship compound, FT218, is on its way towards approval with the FDA. FT218 once nightly dose has been proven more efficient and better accepted by patients than competing products. Potential obstacle towards approval seen as minimal risk. Narcolepsy is an over-$1 bi...

The CBD market has recently seen a multi-billion dollar deal and HempFusion going public. Co-Founder/CEO Dr. Jason Mitchell and CCO Danny Brody join the show to discuss radical transparency, methodical growth and becoming more efficient during Covid. We also cover the opportunity ...

Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on February 23, 2021 PR Newswire DUBLIN , Feb. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 fourth quarter and full year fina...

Jazz Pharmaceuticals (NASDAQ: JAZZ) recently announced plans to acquire cannabinoid-focused biotech GW Pharmaceuticals (NASDAQ: GWPH) in a deal valued at $7.2 billion. In this Motley Fool Live video recorded on Feb. 3 , Fool.com writers Keith Speights and Brian Orell...